A novel combined transoral and transcervical surgical approach for recurrent metastatic medullary thyroid cancer to the parapharyngeal space
SA Lajud, JA Aponte-Ortiz, M Garraton… - Journal of Robotic …, 2020 - Springer
Medullary thyroid cancer (MTC) represents less than 1% of all thyroid cancers. Complete
surgical resection remains the mainstay of treatment for locoregional disease. Unfortunately …
surgical resection remains the mainstay of treatment for locoregional disease. Unfortunately …
A novel combined transoral and transcervical surgical approach for recurrent metastatic medullary thyroid cancer to the parapharyngeal space
SA Lajud, JA Aponte-Ortiz… - Journal of robotic …, 2020 - pubmed.ncbi.nlm.nih.gov
Medullary thyroid cancer (MTC) represents less than 1% of all thyroid cancers. Complete
surgical resection remains the mainstay of treatment for locoregional disease. Unfortunately …
surgical resection remains the mainstay of treatment for locoregional disease. Unfortunately …
A novel combined transoral and transcervical surgical approach for recurrent metastatic medullary thyroid cancer to the parapharyngeal space.
SA Lajud, JA Aponte-Ortiz, M Garraton… - Journal of Robotic …, 2019 - europepmc.org
Medullary thyroid cancer (MTC) represents less than 1% of all thyroid cancers. Complete
surgical resection remains the mainstay of treatment for locoregional disease. Unfortunately …
surgical resection remains the mainstay of treatment for locoregional disease. Unfortunately …
A novel combined transoral and transcervical surgical approach for recurrent metastatic medullary thyroid cancer to the parapharyngeal space
SA Lajud, JA Aponte-Ortiz, M Garraton… - Journal of Robotic …, 2020 - search.proquest.com
Medullary thyroid cancer (MTC) represents less than 1% of all thyroid cancers. Complete
surgical resection remains the mainstay of treatment for locoregional disease. Unfortunately …
surgical resection remains the mainstay of treatment for locoregional disease. Unfortunately …